Results 161 to 170 of about 7,681 (214)
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US. [PDF]
Int J Chron Obstruct Pulmon DisShaikh A +6 more
europepmc +1 more source
Effect of Tiotropium on eye findings in the treatment of chronic obstructive pulmonary disease. [PDF]
BMC Pulm MedAksoy HB, Koç H.
europepmc +1 more source
Asthma: onset at young, persist when grow up. [PDF]
Transl PediatrSiu KK, Lin LY, Kwok WC.
europepmc +1 more source
Bioorganic Chemistry, Toxinology, and Pharmaceutical Uses of <i>Datura</i> Metabolites and Derivatives. [PDF]
Toxins (Basel)Thawabteh AM +6 more
europepmc +1 more source
Application of Discrete Event Simulation Models for COPD Management: A Systematic Review. [PDF]
Int J Chron Obstruct Pulmon DisShuai L +7 more
europepmc +1 more source
One size does not fit all: uncontrolled T2 inflammation on tezepelumab-a case series. [PDF]
Allergy Asthma Clin ImmunolTardif A +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2002
Tiotropium bromide is an anticholinergic bronchodilator that antagonises muscarinic M(1), M(2) and M(3) receptors. It dissociates more slowly from M(1) receptors and, importantly, from M(3) receptors (which are located in bronchial smooth muscle) than from M(2) receptors and subsequently has a long duration of action permitting once-daily ...
Karen M, Hvizdos, Karen L, Goa
+6 more sources
Tiotropium bromide is an anticholinergic bronchodilator that antagonises muscarinic M(1), M(2) and M(3) receptors. It dissociates more slowly from M(1) receptors and, importantly, from M(3) receptors (which are located in bronchial smooth muscle) than from M(2) receptors and subsequently has a long duration of action permitting once-daily ...
Karen M, Hvizdos, Karen L, Goa
+6 more sources
Chest, 2004
Tiotropium bromide is a novel, inhaled, once-daily anticholinergic bronchodilator that has recently been approved in the United States for use in patients with COPD. Its unique feature is the persistence of bronchodilation for > 24 h due to prolonged M(3) muscarinic receptor blockade.
Cynthia Mundy, Peter Kirkpatrick
openaire +3 more sources
Tiotropium bromide is a novel, inhaled, once-daily anticholinergic bronchodilator that has recently been approved in the United States for use in patients with COPD. Its unique feature is the persistence of bronchodilation for > 24 h due to prolonged M(3) muscarinic receptor blockade.
Cynthia Mundy, Peter Kirkpatrick
openaire +3 more sources
Tijdschrift voor praktijkondersteuning, 2015
Tiotropium is het eerste langwerkende inhaleerbare parasympathicolyticum dat sinds 2001 internationaal beschikbaar is gekomen voor de behandeling van chronisch obstructieve luchtwegaandoeningen (COPD). In dit artikel worden de geregistreerde indicatie, de beschikbare handelsvormen, het werkingsmechanisme, de werkzaamheid en bijwerkingen beschreven, en ...
Dick Bijl, Kenny van Deventer
openaire +1 more source
Tiotropium is het eerste langwerkende inhaleerbare parasympathicolyticum dat sinds 2001 internationaal beschikbaar is gekomen voor de behandeling van chronisch obstructieve luchtwegaandoeningen (COPD). In dit artikel worden de geregistreerde indicatie, de beschikbare handelsvormen, het werkingsmechanisme, de werkzaamheid en bijwerkingen beschreven, en ...
Dick Bijl, Kenny van Deventer
openaire +1 more source
Chest, 2000
In spite of growing interest in and knowledge about the causes and progression of COPD, neither the assessment nor pharmacologic treatment of this condition is currently ideal. Tiotropium is the first new treatment for COPD in many years. Tiotropium is a long-acting anticholinergic agent that has a potential role as a once-daily maintenance treatment ...
openaire +2 more sources
In spite of growing interest in and knowledge about the causes and progression of COPD, neither the assessment nor pharmacologic treatment of this condition is currently ideal. Tiotropium is the first new treatment for COPD in many years. Tiotropium is a long-acting anticholinergic agent that has a potential role as a once-daily maintenance treatment ...
openaire +2 more sources